1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The C-reactive protein/albumin (CRP/Alb) ratio is associated with outcome in septic patients. However, as an inflammation-based score, its prognostic value for cancer has scarcely been investigated.

          Related collections

          Author and article information

          Journal
          Ann. Surg. Oncol.
          Annals of surgical oncology
          Springer Nature
          1534-4681
          1068-9265
          Feb 2017
          : 24
          : 2
          Affiliations
          [1 ] Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
          [2 ] Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
          [3 ] Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China.
          [4 ] Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China. luoguopei@hotmail.com.
          [5 ] Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China. luoguopei@hotmail.com.
          [6 ] Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China. luoguopei@hotmail.com.
          [7 ] Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China. yuxianjun@fudanpci.org.
          [8 ] Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China. yuxianjun@fudanpci.org.
          [9 ] Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China. yuxianjun@fudanpci.org.
          Article
          10.1245/s10434-016-5579-3
          10.1245/s10434-016-5579-3
          27650825
          d5cc13c8-cf2a-49c1-b5bc-ff10f151c8df
          History

          Comments

          Comment on this article